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Introduction / objectives
Immunity to measles, rubella, mumps, and varicella
(MMRV) is an important part of infection control
among healthcare-workers (HCWs).To evaluate the cost
effectiveness of prevaccination screening of HCWs
against MMRV.
Methods
A structured survey form,including data of age, gender,
job category, length of employment, history of MMRV
infections and status of MMRV vaccinations, was
applied to HCWs.Serologic screening for MMRV was
performed on HCWs using enzyme-linked immunosor-
bent assay (EIA).The cost of each test for MMR was
€2.5 and €5 for varicella.In a cost-effectiveness analysis,
MMR
®(supplied by Ministry of Health from Serum
Institute of India for €2.5) and Varilrix
®(GlaxoSmithK-
line-cheapest vaccination in the marketplace-€25) vac-
cines were used.
Results
One thousand and two hundred fifty-five HCWs were
tested.Of these, 798 (64%) were female and the age ran-
ged from 19 to 60 years (median 30).The median length
of employment was 5 (≤1-47 years).Of the employees
examined, 94% were immune to measles, 97% to rubella,
90% to mumps, 98% to varicella.The cost for screening
and then vaccination was €9942.5 for MMR and €6815
for varicella.The cost for vaccination without screening
was €2422.5 for MMR and €15900 for varicella.The cost
of vaccination without screening was significantly
expensive (cost difference: €9085) for varicella, however
cheap for MMR (cost difference: €7520).
Conclusion
For the immunization against MMRV in HCWs, immu-
nity rate, screening and vaccine cost and side effects
should be considered in developing countries. Cheaper
vaccines may be cost effective for vaccination without
screening, however prescreening may be rule out side
effects.
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